Dementia in the News

CURE Alzheimer's Fund (October 18, 2012): $5.4 Million Awarded for Research to Guide Alzheimer's Drug Development

Publication Date: 
Thu, 10/18/2012

Understanding who is most susceptible to Alzheimer's disease and developing early detection models, effective therapies and possibly a cure, is the goal of the largest single private scientific grant ever invested in Alzheimer's Whole Genome Sequencing (WGS) focused on families afficted with Alzheimer's disease.

A $5.4 million contribution announced today from the non-profit Cure Alzheimer's Fund to Massachusetts General Hospital (MGH) will allow state-of-the-art whole genome DNA sequencing to further understand the genetic roots of Alzheimer's disease.

MIT News (October 16, 2012): Brain's Language Center has Multiple Roles

Publication Date: 
Tue, 10/16/2012

A century and a half ago, French physician Pierre Paul Broca found that patients with damage to part of the brain's frontal lobe were unable to speak more than a few words. Later dubbed Broca's area, this region is believed to be critical for speech production and some aspects of language comprehension.

U.S. News & World Report (October 11, 2012): The Latest Outlook on Alzheimer's

Publication Date: 
Thu, 10/11/2012

More than 5 million Americans have Alzheimer's disease, and the nonprofit Alzheimer's Association projects that, barring major advances, 11 million to 16 million will have it by 2050 - at an annual cost of $1.1 trillion in today's dollars. In May, the government announced the first national plan to combat Alzheimer's, and one focus is the role of beta-amyloid plaques in the brain, a leading suspect in this form of dementia. U.S.

New York Times (October 10, 2012): Three Drugs to be Tested to Stave off Alzheimer's

Publication Date: 
Wed, 10/10/2012

Scientists have selected three different types of Alzheimer's drugs to be tested in the first large-scale international attempt to prevent the disease in people who are otherwise doomed to get it.

National Institute on Aging (October 1, 2012): Risk Gene for Alzheimer's Disease Associated with Lower Brain Amyloid

Publication Date: 
Mon, 10/01/2012

Researchers investigating a known gene risk factor for Alzheimer's dsiease discovered it is associated with lower levels of beta amyloid - a brain protein involved in Alzheimer's - in cognitively healthy older people. The findings suggest that a mechanism other than one related to beta amyloid accumulation may influence disease risk associated with the gene. The study, by researchers at the National Institute on Aging (NIA) at the National Institutes of Health, was published online September 27, 2012 in the journal Biological Psychiatry.

Agencia EFE Salud (September 26, 2012): El alzhéimer es la epidemia silente del siglo XXI

Publication Date: 
Wed, 09/26/2012

Teresa Gómez Isla estuvo este verano dando un curso magistral sobre la enfermedad de Alzheimer en la Universidad Internacional Menéndez Pelayo, en Santander.

Ahora, desde Boston, esta investigadora, quien ha tratado al expresidente de la Generalitat catalana Pasqual Maragall, que sufre alzhéimer desde 2007,  habla con EFEsalud para analizar esta grave enfermedad.

National Institutes of Health (September 17, 2012): New Brain Cleaning System Discovered

Publication Date: 
Mon, 09/17/2012

Scientists have discovered a system that drains waste products from the brain. The finding may reveal ways to treat neurodegenerative disorders like Alzheimer's disease.

New York Times (September 11, 2012): A Longer Life is Lived in Company

Publication Date: 
Tue, 09/11/2012

YOU die alone, philosophers say. But you could die sooner if you live your life in loneliness. Close connections to friends and family may ward off poor health and premature death, recent research suggests.

AlzForum (September 6, 2012): Europe Asks if Reforming Health Habits Can Prevent Dementia

Publication Date: 
Thu, 09/06/2012

With an Alzheimer's epidemic looming, scientists, health officials, policymakers and the public are asking if anything can slow down this disease. Some prevention trials in the U.S. will test drug interventions but what about lifestyle modifications, such as eating better or exercising more? Some data suggest that tweaks in our routine could help, but in 2010 a panel from the National Institutes of Health deemed that evidence insufficient to justify formal recommendations.

Syndicate content